RE-BVS – Piemonte Repository

Sfoglia per AUTORE
LOMBARDI P
Collezione ASL VCO

Items : 3

Post-induction management in left-sided RAS and BRAF wild-type metastatic colorectal cancer patients treated with first-line anti-EGFR-based doublet regimens: A multicenter “real-life” study in Tumori

2021
ASL Torino 4
ASL Asti
ASL Biella
ASL Torino 5
ASL VCO
ASL Vercelli

Patruno LV; Filippi R; Ribelli M; Ghidini M; Nigro O; Gelsomino F; Zurlo IV; Fulgenzi C; Lombardi P; Depetris I; Giampieri R; Morelli C; Di Marino P; Di Pietro FR; Zanaletti N; Zoratto F; Roberto M; Petrillo A; Porzio G; Parisi A;

Antiplatelet treatment in patients with conservatively managed spontaneous coronaryartery dissection. results of the multicenter international registry disco in European Heart Journal, Supplement

2021
ASL Asti
ASL VCO
ASL Vercelli

Giacobbe F; Cerrato E; Quadri G; Bianco M; Macaya F; Porto I; Cavallino C; Meynet I; Mori R; Biolè C; Lo Savio L; Ferrari F; Mariani F; Palacio S; Bettari L; Boi A; Tomassini F; Perrelli M; Scappaticci M; Buccheri D; Rognoni A; Rolfo C; Franzé A; Erriquez A; Pavani M; Gagnor A; Celentani D; Truffa Giachet A; Barbero U; et alii...

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.

2019
ASL Biella
ASL VCO
AO Ordine Mauriziano
AOU Città della Salute di Torino

Lièvre A; Montagnani F; Vasile E; Brac C; Aglietta M; Clerico M; Passardi A; Buscaglia P; Meurisse A; Pasquini G; Neuzillet C; Falcone A; Spadi R; Edeline J; Sperti E; Musettini G; Satolli MA; Vernerey D; De Luca E; Vivaldi C; Lombardi P; Vienot A; Casadei-Gardini A; Leone F; Fornaro L;